Open Access
KDM2A/B lysine demethylases and their alternative isoforms in development and disease
Тип публикации: Journal Article
Дата публикации: 2018-10-08
scimago Q1
wos Q2
БС2
SJR: 1.702
CiteScore: 4.6
Impact factor: 4.5
ISSN: 19491034, 19491042, 0864084X, 20755635, 16786602, 19822278, 27463869
PubMed ID:
30059280
Cell Biology
Краткое описание
Aberrant levels of histone modifications lead to chromatin malfunctioning and consequently to various developmental defects and human diseases. Therefore, the proteins bearing the ability to modify histones have been extensively studied and the molecular mechanisms of their action are now fairly well understood. However, little attention has been paid to naturally occurring alternative isoforms of chromatin modifying proteins and to their biological roles. In this review, we focus on mammalian KDM2A and KDM2B, the only two lysine demethylases whose genes have been described to produce also an alternative isoform lacking the N-terminal demethylase domain. These short KDM2A/B-SF isoforms arise through alternative promoter usage and seem to play important roles in development and disease. We hypothesise about the biological significance of these alternative isoforms, which might represent a more common evolutionarily conserved regulatory mechanism.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.
Топ-30
Журналы
|
1
2
|
|
|
Nature Chemical Biology
2 публикации, 6.06%
|
|
|
Theriogenology
2 публикации, 6.06%
|
|
|
Signal Transduction and Targeted Therapy
1 публикация, 3.03%
|
|
|
Open Biology
1 публикация, 3.03%
|
|
|
FASEB Journal
1 публикация, 3.03%
|
|
|
Frontiers in Genetics
1 публикация, 3.03%
|
|
|
Frontiers in Molecular Biosciences
1 публикация, 3.03%
|
|
|
Protein Journal
1 публикация, 3.03%
|
|
|
PLoS ONE
1 публикация, 3.03%
|
|
|
Trends in Genetics
1 публикация, 3.03%
|
|
|
Journal of Cellular and Molecular Medicine
1 публикация, 3.03%
|
|
|
Advances in Experimental Medicine and Biology
1 публикация, 3.03%
|
|
|
Experimental and Therapeutic Medicine
1 публикация, 3.03%
|
|
|
Cells
1 публикация, 3.03%
|
|
|
Oncogene
1 публикация, 3.03%
|
|
|
Current Stem Cell Research and Therapy
1 публикация, 3.03%
|
|
|
Science advances
1 публикация, 3.03%
|
|
|
Hepatoma Research
1 публикация, 3.03%
|
|
|
Cell Regeneration
1 публикация, 3.03%
|
|
|
Journal of Genetics and Genomics
1 публикация, 3.03%
|
|
|
Communications Biology
1 публикация, 3.03%
|
|
|
Cell
1 публикация, 3.03%
|
|
|
RSC Medicinal Chemistry
1 публикация, 3.03%
|
|
|
Future Medicinal Chemistry
1 публикация, 3.03%
|
|
|
Results and Problems in Cell Differentiation
1 публикация, 3.03%
|
|
|
Journal of Ovarian Research
1 публикация, 3.03%
|
|
|
Pathology Research and Practice
1 публикация, 3.03%
|
|
|
1
2
|
Издатели
|
2
4
6
8
10
|
|
|
Springer Nature
10 публикаций, 30.3%
|
|
|
Elsevier
7 публикаций, 21.21%
|
|
|
Cold Spring Harbor Laboratory
3 публикации, 9.09%
|
|
|
Frontiers Media S.A.
2 публикации, 6.06%
|
|
|
The Royal Society
1 публикация, 3.03%
|
|
|
Federation of American Societies for Experimental Biology (FASEB)
1 публикация, 3.03%
|
|
|
Public Library of Science (PLoS)
1 публикация, 3.03%
|
|
|
Wiley
1 публикация, 3.03%
|
|
|
Spandidos Publications
1 публикация, 3.03%
|
|
|
MDPI
1 публикация, 3.03%
|
|
|
Bentham Science Publishers Ltd.
1 публикация, 3.03%
|
|
|
American Association for the Advancement of Science (AAAS)
1 публикация, 3.03%
|
|
|
OAE Publishing Inc.
1 публикация, 3.03%
|
|
|
Royal Society of Chemistry (RSC)
1 публикация, 3.03%
|
|
|
Taylor & Francis
1 публикация, 3.03%
|
|
|
2
4
6
8
10
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
34
Всего цитирований:
34
Цитирований c 2025:
11
(33.33%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Vacík T. et al. KDM2A/B lysine demethylases and their alternative isoforms in development and disease // Nucleus. 2018. Vol. 9. No. 1. pp. 431-441.
ГОСТ со всеми авторами (до 50)
Скопировать
Vacík T., Lađinović D., Raška I., Raska I. KDM2A/B lysine demethylases and their alternative isoforms in development and disease // Nucleus. 2018. Vol. 9. No. 1. pp. 431-441.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1080/19491034.2018.1498707
UR - https://doi.org/10.1080/19491034.2018.1498707
TI - KDM2A/B lysine demethylases and their alternative isoforms in development and disease
T2 - Nucleus
AU - Vacík, Tomáš
AU - Lađinović, Dijana
AU - Raška, Ivan
AU - Raska, I
PY - 2018
DA - 2018/10/08
PB - Taylor & Francis
SP - 431-441
IS - 1
VL - 9
PMID - 30059280
SN - 1949-1034
SN - 1949-1042
SN - 0864-084X
SN - 2075-5635
SN - 1678-6602
SN - 1982-2278
SN - 2746-3869
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2018_Vacík,
author = {Tomáš Vacík and Dijana Lađinović and Ivan Raška and I Raska},
title = {KDM2A/B lysine demethylases and their alternative isoforms in development and disease},
journal = {Nucleus},
year = {2018},
volume = {9},
publisher = {Taylor & Francis},
month = {oct},
url = {https://doi.org/10.1080/19491034.2018.1498707},
number = {1},
pages = {431--441},
doi = {10.1080/19491034.2018.1498707}
}
Цитировать
MLA
Скопировать
Vacík, Tomáš, et al. “KDM2A/B lysine demethylases and their alternative isoforms in development and disease.” Nucleus, vol. 9, no. 1, Oct. 2018, pp. 431-441. https://doi.org/10.1080/19491034.2018.1498707.